The Cigna Group (CI)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $78.26B
Last updated: Nov 17, 2026 at 11:05 AM ET
The Cigna Group (CI) Earnings: Report Dates and Results
The Cigna Group (CI) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, The Cigna Group reported EPS of $7.98, above the $7.46 estimate. It beat the EPS estimate in 7 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CI has an expected report date of Feb 3, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 9.4% below the $8.08 reported for the quarter ended Dec 31, 2025.
CI Earnings Call
The latest CI earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, CI beat 37 and missed 3. Revenue for the quarter ended Sep 30, 2026 was $73.72B, up 5.6% from $69.81B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $7.98 | $7.46 | $7.42 - $7.71 | +6.97% | Beat | +1.9% | 23 | 1 up, 1 down | Nov 5, 2026 | $73.72B |
| Jun 30, 2026 | $7.78 | $7.58 | $7.53 - $7.73 | +2.64% | Beat | +8.1% | 22 | 2 up, 0 down | Jul 30, 2026 | $71.61B |
| Mar 31, 2026 | $7.79 | $7.61 | $7.09 - $7.92 | +2.37% | Beat | +15.6% | 22 | 0 up, 2 down | Apr 30, 2026 | $68.76B |
| Dec 31, 2025 | $8.08 | $7.88 | $7.82 - $8.00 | +2.54% | Beat | +21.7% | 22 | 1 up, 1 down | Feb 5, 2026 | $72.30B |
| Sep 30, 2025 | $7.83 | $7.64 | $7.41 - $8.28 | +2.49% | Beat | +4.3% | 23 | 1 up, 4 down | Oct 30, 2025 | $69.81B |
| Jun 30, 2025 | $7.20 | $7.15 | $7.08 - $7.39 | +0.70% | Beat | +7.1% | 22 | 1 up, 1 down | Jul 31, 2025 | $67.23B |
| Mar 31, 2025 | $6.74 | $6.35 | $5.81 - $6.78 | +6.14% | Beat | +4.2% | 21 | 1 up, 3 down | May 2, 2025 | $65.54B |
| Dec 31, 2024 | $6.64 | $7.82 | $7.72 - $8.10 | -15.09% | Miss | -2.2% | 22 | 2 up, 0 down | Jan 30, 2025 | $64.01B |
| Sep 30, 2024 | $7.51 | $7.25 | $7.10 - $7.67 | +3.59% | Beat | +10.9% | 20 | 1 up, 0 down | Oct 31, 2024 | $62.69B |
| Jun 30, 2024 | $6.72 | $6.42 | $6.29 - $6.71 | +4.67% | Beat | +9.6% | 21 | 1 up, 0 down | Aug 1, 2024 | $60.48B |
| Mar 31, 2024 | $6.47 | $6.22 | $6.04 - $6.54 | +4.02% | Beat | +19.6% | 21 | 2 up, 0 down | May 1, 2024 | $57.24B |
| Dec 31, 2023 | $6.79 | $6.54 | $6.45 - $6.69 | +3.82% | Beat | +36.9% | 20 | 1 up, 0 down | Feb 2, 2024 | $49.60B |
| Sep 30, 2023 | $6.77 | $6.68 | $6.58 - $6.84 | +1.35% | Beat | +12.1% | 19 | 0 up, 0 down | Nov 2, 2023 | $49.01B |
| Jun 30, 2023 | $6.13 | $6.04 | $5.54 - $6.24 | +1.49% | Beat | -1.4% | 21 | 0 up, 1 down | Aug 3, 2023 | $48.61B |
| Mar 31, 2023 | $5.41 | $5.24 | $4.96 - $6.13 | +3.24% | Beat | -10.0% | 21 | 2 up, 0 down | May 5, 2023 | $46.46B |
| Dec 31, 2022 | $4.96 | $4.87 | $4.74 - $5.01 | +1.85% | Beat | +4.0% | 21 | 0 up, 0 down | Feb 3, 2023 | $45.36B |
| Sep 30, 2022 | $6.04 | $5.71 | $5.56 - $6.07 | +5.78% | Beat | +5.4% | 18 | 3 up, 0 down | Nov 3, 2022 | $46.93B |
| Jun 30, 2022 | $6.22 | $5.49 | $5.04 - $5.85 | +13.30% | Beat | +18.7% | 21 | 0 up, 0 down | Aug 4, 2022 | $45.39B |
| Mar 31, 2022 | $6.01 | $5.18 | $4.63 - $5.45 | +16.02% | Beat | +27.1% | 19 | 2 up, 2 down | May 6, 2022 | $44.01B |
| Dec 31, 2021 | $4.77 | $4.71 | $4.50 - $5.14 | +1.27% | Beat | +35.9% | 21 | 0 up, 0 down | Feb 3, 2022 | $45.88B |
| Sep 30, 2021 | $5.73 | $5.21 | $4.84 - $5.68 | +9.98% | Beat | +29.9% | 23 | N/A | Nov 4, 2021 | $44.29B |
| Jun 30, 2021 | $5.24 | $4.97 | $4.45 - $5.67 | +5.43% | Beat | -9.8% | 21 | N/A | Aug 5, 2021 | $43.12B |
| Mar 31, 2021 | $4.73 | $4.40 | $3.99 - $5.56 | +7.50% | Beat | +0.9% | 20 | N/A | May 7, 2021 | $40.84B |
| Dec 31, 2020 | $3.51 | $3.69 | $3.49 - $3.97 | -4.88% | Miss | -18.6% | 22 | N/A | Feb 4, 2021 | $46.08B |
| Sep 30, 2020 | $4.41 | $4.23 | $4.01 - $4.58 | +4.26% | Beat | -2.9% | 23 | N/A | Nov 5, 2020 | $40.99B |
| Jun 30, 2020 | $5.81 | $5.16 | $4.73 - $6.11 | +12.60% | Beat | +35.1% | 24 | N/A | Jul 30, 2020 | $39.29B |
| Mar 31, 2020 | $4.69 | $4.36 | $4.11 - $5.14 | +7.57% | Beat | +20.3% | 22 | N/A | Apr 30, 2020 | $38.20B |
| Dec 31, 2019 | $4.31 | $4.20 | $4.15 - $4.28 | +2.62% | Beat | +75.2% | 25 | N/A | Feb 6, 2020 | $38.35B |
| Sep 30, 2019 | $4.54 | $4.36 | $4.05 - $4.61 | +4.13% | Beat | +18.2% | 25 | N/A | Oct 31, 2019 | $38.61B |
| Jun 30, 2019 | $4.30 | $3.74 | $3.58 - $4.34 | +14.97% | Beat | +10.5% | 23 | N/A | Aug 1, 2019 | $38.84B |
| Mar 31, 2019 | $3.90 | $3.73 | $3.47 - $4.63 | +4.56% | Beat | -5.1% | 24 | N/A | May 2, 2019 | $37.95B |
| Dec 31, 2018 | $2.46 | $2.49 | $1.66 - $2.74 | -1.20% | Miss | +26.8% | 17 | N/A | Feb 1, 2019 | $14.22B |
| Sep 30, 2018 | $3.84 | $3.44 | $3.13 - $3.60 | +11.63% | Beat | +35.7% | 21 | N/A | Nov 1, 2018 | $11.46B |
| Jun 30, 2018 | $3.89 | $3.33 | $3.03 - $3.70 | +16.82% | Beat | +33.7% | 19 | N/A | Aug 2, 2018 | $11.48B |
| Mar 31, 2018 | $4.11 | $3.39 | $3.20 - $3.68 | +21.24% | Beat | +48.4% | 19 | N/A | May 3, 2018 | $11.41B |
| Dec 31, 2017 | $1.94 | $1.87 | $1.79 - $2.14 | +3.74% | Beat | +3.7% | 19 | N/A | Feb 1, 2018 | $10.42B |
| Sep 30, 2017 | $2.83 | $2.36 | $2.25 - $2.47 | +19.92% | Beat | +45.9% | 14 | N/A | Nov 2, 2017 | $10.49B |
| Jun 30, 2017 | $2.91 | $2.48 | $2.36 - $2.56 | +17.34% | Beat | +47.0% | 18 | N/A | Aug 4, 2017 | $10.43B |
| Mar 31, 2017 | $2.77 | $2.46 | N/A | +12.60% | Beat | +19.4% | N/A | N/A | May 5, 2017 | $10.47B |
| Dec 31, 2016 | $1.87 | $1.74 | N/A | +7.47% | Beat | 0.0% | N/A | N/A | Feb 2, 2017 | $9.94B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $29.85, up 9.2% from the year before. It was $8.11 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $29.85 | +9.2% |
| Dec 31, 2024 | $27.34 | +8.9% |
| Dec 31, 2023 | $25.10 | +8.0% |
| Dec 31, 2022 | $23.23 | +13.5% |
| Dec 31, 2021 | $20.47 | +11.1% |
| Dec 31, 2020 | $18.42 | +8.0% |
| Dec 31, 2019 | $17.05 | +19.2% |
| Dec 31, 2018 | $14.30 | +36.8% |
| Dec 31, 2017 | $10.45 | +28.9% |
| Dec 31, 2016 | $8.11 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,600 words across 14 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 9,619 | 14 | |
| 2026Q2 | Jun 30, 2026 | 8,484 | 14 | |
| 2026Q1 | Mar 31, 2026 | 10,187 | 15 | |
| 2025Q4 | Dec 31, 2025 | 9,324 | 15 | |
| 2025Q3 | Sep 30, 2025 | 6,076 | 8 | |
| 2025Q2 | Jun 30, 2025 | 9,442 | 14 | |
| 2025Q1 | Mar 31, 2025 | 9,785 | 14 | |
| 2024Q4 | Dec 31, 2024 | 9,969 | 19 |
2026Q3 Earnings Call
Opening remarks
Ralph Giacobbe Senior Vice President of Investor Relations Great, thanks. Good morning. Thank you for joining today's call. I am Ralph Giacobbe, Senior Vice President of Investor Relations. With me on the line this morning are Brian C. Evanko, Cigna Group's President and Chief Executive Officer, and Ann Dennison, Chief Financial Officer. In our remarks today, Brian and Ann will cover a number of topics, including our third-quarter 2026 financial results and our financial outlook for 2026. Following their prepared remarks, Brian and Ann will be available for Q&A. As noted in our earnings release, when describing our financial results, we use certain financial measures, including adjusted income from operations and adjusted revenues, that are not determined in accordance with accounting principles generally accepted in the United States, otherwise known as GAAP. A reconciliation of these measures to the most directly comparable GAAP measures, shareholders' net income and total revenues, respectively, is contained in today's earnings release, which is posted in the Investor Relations section of cignagroup.com. We use the terms adjusted income from operations and adjusted earnings per share as our principal measures of financial performance. In our remarks today, we will be making some forward-looking statements, including statements regarding our outlook for 2026 and future performance. These statements are subject to risks and uncertainties that could cause actual results to differ materially from our current expectations. A description of these risks and uncertainties is contained in the cautionary note to today's earnings release and in our most recent reports filed with the SEC. Regarding our results in the third quarter, we recorded after-tax special item charges of $146 million, or $0.55 per share. Details of the special items are included in our quarterly financial supplement. Additionally, please note that when we make prospective comments regarding financial performance, including our full-year 2026 outlook, we will do so on a basis that includes the potential impact of future share repurchases and anticipated 2026 dividends. With that, I will turn the call over to Brian.
Brian C. Evanko President and Chief Executive Officer Thanks, Ralph. Good morning, everyone, and thank you for joining our call. I am pleased to share that the Cigna Group delivered strong performance in the third quarter as we continue executing on our strategy. Today, I will cover our results for the quarter and key drivers, our profitable growth strategy and how we are advancing toward our long-term earnings growth algorithm of 10% to 14%, which we laid out at our recent Investor Day, as well as how our strategic growth framework positions us to build momentum in 2027. Then Ann will share additional details about our financial results and outlook for the rest of the year, and we will take your questions.
Frequently Asked Questions About CI
When is The Cigna Group's next earnings date?
The Cigna Group's next earnings report is expected for Feb 3, 2027.
Did CI beat earnings estimates last quarter?
Yes. The Cigna Group reported EPS of $7.98 for the quarter ended Sep 30, 2026, above the $7.46 estimate, a 6.97% surprise.
What EPS do analysts expect from CI next quarter?
The consensus EPS estimate for The Cigna Group for the quarter ending Dec 31, 2026 is $7.32 from 28 analysts, with estimates from $6.91 to $7.83.
How often does CI beat earnings estimates?
The Cigna Group beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +1.09%.
CI pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors